Trusted by top labs worldwide, NeoBiotechnologies delivers high-quality antibodies and recombinants—direct from our scientists to your lab bench.
We’re the original manufacturer behind the antibodies you rely on — now delivering unmatched quality and specificity straight to your lab.
We’re not just another supplier — we’re the original developers and manufacturers of the monoclonal antibodies and recombinant proteins that power groundbreaking research and innovation. For decades, our products have set the benchmark for quality and specificity across academia, biotech, and diagnostics.
Dr. Tandon is the President and CEO of NEOBIOTECHNOLOGIES, a leading antibody company based in Silicon Valley, California. His passion for antibodies is evident in all he does and has been a pioneer in the antibody industry for the past four decades.
At NeoBiotechnologies, we offer the most stringently validated primary antibodies on the market — delivering the reliability and reproducibility your research demands.
Reliable results start with the right reagents. Our antibodies undergo thorough validation processes to ensure specificity, sensitivity, and reproducibility across applications like Western blotting, immunofluorescence, flow cytometry, and more. Don't leave your data to chance—choose antibodies that are tested and trusted by researchers worldwide.
Antibodies are critical tools in the quest to understand fundamental biological processes, diagnose diseases and develop new therapies.
Additionally, we assist in confirming the functionality of the antibody in specific application(s) of interest. Application verification is employed to guarantee the antibody’s efficacy not only in a singular application but also across various other applications, demonstrating its accurate target binding.
One aspect that sets NeoBiosciences apart from other antibody manufacturers is that we sequence all our products. This added quality control step ensures reproducibility and lot-to-lot consistency.
At NeoBiotechnologies, we use both Protein Array analysis and Tissue Microarrays (TMAs) as powerful tools in our antibody validation process.
At NeoBiotechnologies, we go beyond standard antibody production. Every monoclonal antibody we offer is validated through the most stringent, application-specific testing to ensure true monospecificity and consistent performance.
At NeoBiotechnologies, excellence isn’t optional — it’s built into everything we do. Our scientists have screened millions of antibodies to curate a best-in-class portfolio targeting the human proteome. With a 98% rejection rate, only the highest-performing antibodies make it through our rigorous selection process.
Explore the newest developments, product launches, scientific breakthroughs, and company updates from NeoBiotechnologies.
At NeoBiotechnologies, our commitment to quality and precision is reflected in the success of our customers. Here’s what researchers and institutions around the world have to say about working with our antibodies.
Be the first to hear about new antibody releases, validation updates, research insights, and special promotions from NeoBiotechnologies. Join our scientific community and stay one step ahead in your research.
